Literature DB >> 10775564

Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension.

D Rizzoni1, E Porteri, D Guefi, A Piccoli, M Castellano, G Pasini, M L Muiesan, M J Mulvany, E A Rosei.   

Abstract

Structural alterations of small arteries in patients with essential hypertension are characterized by inward eutrophic remodeling. However, small arteries in patients with secondary hypertension, as well as in experimental models of hypertension with high circulating renin, are characterized by inward hypertrophic remodeling, which is characterized by smooth muscle cell hypertrophy in animal models. The aim of our study was to determine whether remodeling of subcutaneous small arteries in patients with secondary forms of hypertension is associated with smooth muscle cell hypertrophy and/or alterations in the elastic modulus of the vessel wall. Fifteen patients with renovascular hypertension, 9 with primary aldosteronism, and 13 with essential hypertension and 9 normotensive subjects were included in the study. A biopsy of subcutaneous fat was taken from all subjects. Small arteries were dissected, and morphology was determined on a micromyograph. Unbiased estimates of cell volume and number were made in fixed material. From the resting tension-internal circumference relation of the small arteries, the incremental elastic modulus was calculated and plotted as a function of wall stress. Blood pressure was greater in patients with essential hypertension, renovascular hypertension, or primary aldosteronism than in normotensive subjects, but no significant difference was observed among the 3 groups of hypertensive patients. The media/lumen ratio, the medial cross-sectional area, and the smooth muscle cell volume were significantly greater in patients with renovascular hypertension than in normotensive subjects and patients with essential hypertension. No difference in cell number or in the elastic properties was observed among the 4 groups of subjects. In conclusion, our data demonstrate for the first time that a pronounced activation of the renin-angiotensin-aldosterone system is associated with vascular smooth muscle cell hypertrophy in human hypertension in a manner similar to that found in animal models.

Entities:  

Mesh:

Year:  2000        PMID: 10775564     DOI: 10.1161/01.hyp.35.4.931

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  22 in total

Review 1.  Aldosterone antagonists in the treatment of hypertension and target organ damage.

Authors:  S Rajagopalan; B Pitt
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  The future of endothelin-receptor antagonism as treatment for systemic hypertension.

Authors:  Gabriel Vorobiof; Burns C Blaxall; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

Review 3.  Interactions between macro- and micro-circulation: are they relevant?

Authors:  Damiano Rizzoni; Carolina De Ciuceis; Massimo Salvetti; Anna Paini; Claudia Rossini; Claudia Agabiti-Rosei; Maria Lorenza Muiesan
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-04-14

Review 4.  Microvascular NADPH oxidase in health and disease.

Authors:  Yao Li; Patrick J Pagano
Journal:  Free Radic Biol Med       Date:  2017-03-06       Impact factor: 7.376

Review 5.  Regression of small resistance artery structural alterations in hypertension by appropriate antihypertensive treatment.

Authors:  Enrico Agabiti-Rosei; Damiano Rizzoni
Journal:  Curr Hypertens Rep       Date:  2010-04       Impact factor: 5.369

Review 6.  Angiotensin and cytoskeletal proteins: role in vascular remodeling.

Authors:  Jos P M Wesselman; Jo G R De Mey
Journal:  Curr Hypertens Rep       Date:  2002-02       Impact factor: 5.369

Review 7.  Small artery remodeling in hypertension and diabetes.

Authors:  Damiano Rizzoni; Enrico Agabiti Rosei
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

Review 8.  Aldosterone: a risk factor for vascular disease.

Authors:  Mario Fritsch Neves; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

Review 9.  Treatment of arterial remodeling in essential hypertension.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

10.  Involvement of prolylcarboxypeptidase in the effect of rutaecarpine on the regression of mesenteric artery hypertrophy in renovascular hypertensive rats.

Authors:  Xu-Ping Qin; Si-Yu Zeng; Hai-Hong Tian; Shui-Xiu Deng; Jun-Fang Ren; Yuan-Bin Zheng; Dai Li; Yuan-Jian Li; Duan-Fang Liao; Shi-You Chen
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-10-31       Impact factor: 2.557

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.